Metraipolis › archive › dc_57cb81f541fb

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial — Europe PMC PMID:41545592

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41545592
DOI
10.1038/s41591-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-06T18:40:44.728Z
SHA-256 of the archived text
c4f5ef91deb06641dc4b45691352cff1fcccf0225beb76feb6b9ef5cb03ef100
Stable URL of this page
https://metraipolis.com/documento/dc_57cb81f541fb

How to cite

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial — Europe PMC PMID:41545592 — Europe PMC (en), https://europepmc.org/article/MED/41545592 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57cb81f541fb (Metraipolis archive dc_57cb81f541fb, sha256 c4f5ef91deb06641dc4b45691352cff1fcccf0225beb76feb6b9ef5cb03ef100)
BibTeX
@misc{dc57cb81f541fb,
  title = {Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial — Europe PMC PMID:41545592},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41545592},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57cb81f541fb; sha256 c4f5ef91deb06641dc4b45691352cff1fcccf0225beb76feb6b9ef5cb03ef100},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41545592. Agents can read the archived copy with the MCP tool read_document.